MATUCCI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 3.089
EU - Europa 2.782
AS - Asia 2.220
SA - Sud America 251
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 6
Totale 8.421
Nazione #
US - Stati Uniti d'America 3.009
RU - Federazione Russa 1.035
SG - Singapore 955
GB - Regno Unito 710
CN - Cina 656
IT - Italia 222
BR - Brasile 204
VN - Vietnam 199
HK - Hong Kong 173
SE - Svezia 157
DE - Germania 142
FR - Francia 133
FI - Finlandia 124
IE - Irlanda 111
KR - Corea 70
CA - Canada 55
UA - Ucraina 43
IN - India 35
PL - Polonia 22
BE - Belgio 19
ES - Italia 19
TR - Turchia 18
JP - Giappone 17
BD - Bangladesh 16
MX - Messico 15
AR - Argentina 14
ID - Indonesia 14
NG - Nigeria 14
ZA - Sudafrica 13
EC - Ecuador 11
IQ - Iraq 8
PK - Pakistan 8
AT - Austria 7
NL - Olanda 7
PH - Filippine 7
IL - Israele 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
KE - Kenya 4
LT - Lituania 4
LV - Lettonia 4
PY - Paraguay 4
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 8.389
Città #
Southend 636
Singapore 499
Jacksonville 357
Moscow 338
Ashburn 297
San Jose 295
Chandler 293
Dallas 187
Hong Kong 171
Woodbridge 161
Ann Arbor 145
Dublin 110
Houston 107
Beijing 104
Verona 85
The Dalles 84
Los Angeles 70
New York 64
Ho Chi Minh City 61
Council Bluffs 56
Nanjing 55
Hanoi 46
Lawrence 42
Princeton 42
Wilmington 40
Munich 39
Jinan 35
Boardman 31
Buffalo 30
Helsinki 30
Seattle 29
Tianjin 28
Sindelfingen 25
Hebei 24
Seoul 23
Shenyang 23
Da Nang 22
Milan 22
Changsha 21
Nanchang 21
Santa Clara 21
São Paulo 21
Orem 20
Warsaw 19
Brussels 18
Hangzhou 18
Montreal 18
Zhengzhou 18
Taizhou 17
Chicago 16
Haikou 16
Chennai 15
Denver 15
Ningbo 15
Redondo Beach 15
Tokyo 15
Abuja 14
Cambridge 14
Columbus 14
Elora 14
Turku 14
Jiaxing 13
San Francisco 12
Atlanta 11
Frankfurt am Main 11
Taiyuan 11
Johannesburg 10
Toronto 10
Haiphong 9
Cagliari 8
London 8
Poplar 8
Brooklyn 7
Clearwater 7
Guangzhou 7
Mexico City 7
Bologna 6
City of London 6
Fuzhou 6
Lanzhou 6
Norwalk 6
Phoenix 6
Quito 6
Redmond 6
Rome 6
Amman 5
Amsterdam 5
Ankara 5
Jakarta 5
Madrid 5
Querétaro 5
Stockholm 5
Tashkent 5
Arco 4
Baku 4
Belo Horizonte 4
Curitiba 4
Dongguan 4
Falkenstein 4
Lahore 4
Totale 5.356
Nome #
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 267
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 260
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 245
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 241
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 241
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 238
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 233
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 229
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 229
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 225
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 221
Presence and role of HLA-C in HIV-1 infection 212
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 208
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 204
Temperature-dependent decay of wheat germ agglutinin activity and its implications for food processing and analysis 203
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 203
Studio di immunogeni per l'induzione di anticorpi neutralizzati ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 202
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 191
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 189
Induction of HIV-1 neutralizing antibodies by fusion complexes 184
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 181
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 179
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 179
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 178
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 177
Studies on the joint cytotoxicity of wheat germ agglutinin and monensin 175
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 170
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 168
HLA-C increases HIV-1 infectivity and is associated with gp120 163
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 152
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 147
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 147
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 146
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 143
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers 141
Presence and Role of HLA-C in HIV-1 Infection 130
Fusion complexes as broad spectrum anti-HIV vaccine 121
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 117
Studio di nuovi immunogeni per l'induzione di anticorpi neutralizzanti ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 108
Use of gp120-CD4-coreceptor fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 106
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 105
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 101
Induction of HIV neutralizing antibodies using fusion complexes and a CD4-independent env 100
HLA-C increase fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 99
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 99
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 92
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 86
HLA class I increases the efficiency of fusion between the HIV-1 envelope and the target cell membrane and is parte of the fusion complex between the gp120/gp41 and the cellular receptors. 79
Tezepelumab in patients with allergic and eosinophilic asthma 50
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study) 47
HLA-C increases HIV-1 infectivity 45
null 33
null 32
Totale 8.421
Categoria #
all - tutte 27.944
article - articoli 13.168
book - libri 0
conference - conferenze 13.884
curatela - curatele 0
other - altro 892
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 107 4 30 5 6 3 22 12 9 32 89
2022/2023843 69 101 76 130 86 193 3 55 91 8 20 11
2023/2024376 13 37 24 47 46 56 11 25 3 30 44 40
2024/20251.135 39 71 18 133 44 37 83 46 209 107 90 258
2025/20263.560 255 127 230 581 951 304 352 173 248 218 51 70
2026/202756 44 12 0 0 0 0 0 0 0 0 0 0
Totale 8.421